Case Report

Low-Molecular-Weight Heparin Use in a Case of Noncardiogenic Multifocal Perinatal Thromboembolic Stroke

Table 1

Thrombophilia Evaluation Performed [10, 11].

TestPerformedTestPerformed

PT and Anti-B2 glycoprotein IgG1 and 2
INR1 and 2Anti-B2 glycoprotein IgM1 and 2
aPTT1 and 2Anti-phosphatidylserine IgG1 and 2
Fibrinogen1 and 2Anti-phosphatidylserine IgM1 and 2
Factor V Leiden 1Heparin cofactor 21 and 2
Prothrombin 202101Homocysteine1 and 2
MTHFR1Lipoprotein (A)1 and 2
Protein C activity1 and 2Antithrombin1 and 2
Protein S activity1 and 2Factor VIII activity2
Anticardiolipin IgG1 and 2Lupus anticoagulant2
Anticardiolipin IgM1 and 2Factor XII activity2
Plasminogen2

PT: prothrombin time; aPTT: activated partial thromboplastin time; INR: international normalized ratio; MTHFR: methylenetetrahydrofolate reductase.
Test performed at day of life no. 4; Test performed at four months of age.